 New gold price target
Most investment banks now predict gold will cross $6,000 an ounce this year. Some analysts expect it to soar as high as $10,000. But if you 're thinking of buying gold this year, do this first. In short: There 's no question 2026 will be a year of great uncertainty, especially as we get closer to the midterm elections. And there 's no question gold could skyrocket as a result. But I have an unfortunate truth to tell you... Most folks will likely run out and buy bullion or mining stocks. Sadly, these folks will likely miss out on the biggest gains. That's because there's a much, much better way to invest in gold right now. Most people know nothing about it. But as I'll show you, if you follow this simple approach, which has nothing to do with bullion, ETFs, or mining stocks, the gains can be absolutely incredible. In one period, it turned every $5,000 invested into more than $1.6 million. Which is why we 're sounding the alarm on gold in 2026. And why it 's critical for you to see our top gold recommendation immediately. Regards, Matt Weinschenk
Director of Research, Stansberry Research
Featured Story from MarketBeat.com Intel's 21% Sell-Off Looks Ugly—But the Numbers Tell Another StorySubmitted by Jeffrey Neal Johnson. Date Posted: 1/27/2026. 
What You Need to Know- Intel delivered fourth-quarter results that exceeded analyst expectations on both the top and bottom lines, despite manufacturing supply constraints.
- Strategic investments from industry leaders and a solid cash position provide the company with a financial safety net to execute its manufacturing roadmap.
- The current stock valuation suggests the market has priced in challenges that management expects to resolve as manufacturing yields improve later this year.
Investors detest uncertainty, and the stock market has a habit of punishing it harshly. In the days following its fourth-quarter earnings report, Intel (NASDAQ: INTC) stock experienced a violent sell-off, falling roughly 21% to the low $40s. The decline was swift and severe, erasing billions of dollars in market capitalization in less than a week as institutional and retail traders alike rushed for the exits. To the casual observer, the red ink on the chart looks like a disaster and suggests a company in deep distress. However, a disciplined review of the financials reveals a disconnect between Intel's stock price and the company's operational performance. While the market panicked over forward guidance, Intel delivered a solid quarter. On September 14th, 2023, something big happened that didn't make the news. The price gap between London gold and Shanghai gold blew out to $120 an ounce. For years, that gap was a few dollars, maybe $5 or $10. A 20x jump in seconds isn't a glitch, it's the system breaking. Traders tried to buy gold in London to sell in Shanghai, but hit a wall. The London vaults were empty. Since that day, gold has hit 53 all-time highs. One stock is positioned to capture the bulk of this wealth transfer. See the full story on this opportunity now. The company reported revenue of $13.7 billion, beating analyst expectations of $13.37 billion. On the bottom line, the results were even stronger: non-GAAP earnings per share (EPS) came in at $0.15, nearly double the consensus estimate of $0.08. Under normal circumstances, beating estimates on both the top and bottom lines sparks a rally. In this case, the opposite happened. The market appears to be pricing in permanent failure based on what the data suggests is a temporary disruption. For value-minded investors willing to look past the immediate volatility and sensational headlines, this sell-off may present a rare entry into a blue-chiptechnology company trading at a distressed price. The Revenue Cliff: A Supply Chain StoryIf the fourth-quarter results were strong, why did the stock plunge? The anxiety centers on guidance for the first quarter of 2026. Management forecasted revenue between $11.7 billion and $12.7 billion. The midpoint of that range, $12.2 billion, was below Wall Street's expectations and created a revenue cliff that spooked investors focused on short-term growth models. Context matters. This lower guidance was not caused by weak demand or canceled orders but by severe supply constraints. According to CFO David Zinsner, the company has effectively depleted its buffer inventory — Intel sold through much of the chips it had sitting on shelves in late 2025. The company is entering 2026 in a hand-to-mouth posture, unable to manufacture chips fast enough to meet rising demand. The supply bottleneck stems from Intel's aggressive technology transition. The company is ramping production of its 18A node, an advanced manufacturing process critical to future competitiveness. Products built on this node, such as the newly launched Core Ultra Series 3 (Panther Lake), are shipping to customers. But advanced manufacturing is notoriously difficult. Company executives said yields are improving steadily, yet they are not yet high enough to support full-volume production. Faced with a silicon shortage, management made a deliberate choice: prioritize wafer supply for the Data Center and AI (DCAI) segment over the Client (PC) segment. Data center chips generally command higher profit margins than laptop or desktop chips. By allocating limited resources to its most profitable customers, Intel is protecting its long-term financial health and relationships with major hyperscalers, even though it depresses near-term revenue. Why the Bottom Won't Fall OutIn prior semiconductor downturns, investors worried Intel might struggle to cover its obligations. That fear is not supported by the company's current balance sheet. Intel exited 2025 with $37.4 billion in cash and short-term investments. That liquidity provides a sizable runway to address yield issues without taking on significant debt or diluting shareholders by issuing more stock. The company's strategy has also been validated by some of the smartest capital in the room. In late 2025, Intel closed a $5 billion investment deal with NVIDIA. That investment is notable because NVIDIA, often seen as a fierce competitor, clearly saw value in Intel's manufacturing roadmap. For retail investors, that vote of confidence from a leading AI player reduces the likelihood that the market's panic over yields is warranted. Intel is also making progress in AI hardware without leaning on risky, expensive acquisitions. While its proposed acquisition of SambaNova Systems collapsed, the company's organic advances tell a different story. Intel's custom ASIC (Application-Specific Integrated Circuit) business has reached an annualized revenue run rate near $1 billion. ASICs are specialized chips optimized for tasks such as running AI models. That performance demonstrates Intel can compete in AI hardware with internal engineering, reducing the need for costly external purchases. Finally, valuation provides a partial floor for the stock. Trading in the low $40s, Intel is at roughly a 2x price-to-book (P/B) ratio (up from as low as 0.8x at $19). That compares with higher multiples for growth semiconductor peers like AMD (NASDAQ: AMD), which trade at about 7x and often price in several years of perfect execution. Intel, by contrast, is priced for disappointment, meaning much of the bad news about yields and supply is already reflected in the stock and limits further downside. Front-Running the Supply FixThe data indicate the first quarter of 2026 will likely mark Intel's operational trough. The supply constraints causing current pain are expected to ease beginning in the second quarter. As yields on the 18A node improve, inventory buffers should rebuild and revenue should move back toward seasonal norms through the remainder of the year. Institutional investors and analysts are already looking past the temporary dip. After the earnings release, Citic Securities upgraded the stock to Buy with a $60.30 price target, and New Street Research raised its target to $50. These firms view the supply bottleneck as a solvable engineering challenge, not a permanent structural problem. For long-term investors, the recent drop creates a compelling window of opportunity. It allows patient capital to buy more of a cash-rich American manufacturer at a distressed price just before production catches up with demand. It also gives investors who exited too early a chance to reestablish positions at a lower cost, with a materially reduced risk that the stock will fall much further now that many worst-case scenarios appear priced in.
This ad is sent on behalf of Stansberry Research, 1125 N Charles St, Baltimore, MD 21201. If you would like to optout from receiving offers from Stansberry Research please click here. | 
